Ads
related to: abbvie pharmaceuticals- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- Read AbbVie Stories
Search results
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation...
Benzinga· 5 days agoNEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP is investigating the merger between Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) and AbbVie, Inc. If you invested in
AbbVie Inc. (NYSE:ABBV) Receives $176.14 Average PT from Brokerages
ETF DAILY NEWS· 2 days agoShares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have earned an average rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the stock, ...
California State Teachers Retirement System Acquires 42,587 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoCalifornia State Teachers Retirement System raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.5% in the 4th quarter, according to the company in ...
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks via Yahoo Finance· 3 days agopharmaceutical companies. It is designed to provide capital appreciation by thoroughly evaluating...
Why Investors Are Eyeing AbbVie Inc (ABBV): The Key Drivers of M
Guru Focus· 3 days agoAbbVie Inc (ABBV, Financial) has recently captured the attention of investors and financial analysts alike, thanks to its solid financial performance and promising growth ...
AbbVie Hit With Investor Lawsuit Over Director Removal Bylaw
Bloomberg Law· 3 days agois the latest company facing a legal challenge to a bylaw that gives its board the power to oust individual members over errors, omissions, or lies in their paperwork. The proposed class action ...
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
InvestorPlace· 14 hours agoOne of the most important sectors globally, it is hard to imagine life without biotech companies...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 2 days agoZacks Rank Teva currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks...
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
BioPharma Dive via Yahoo Finance· 23 hours agoA study abstract shed more light on tirzepatide’s potential in MASH. Elsewhere, Cytokinetics CEO...
Exploring Three High-Growth Euronext Paris Stocks With Substantial Insider Ownership
Simply Wall St. via Yahoo Finance· 5 hours agoAmid a backdrop of heightened inflation and economic uncertainty across Europe, the French market...
Ad
related to: abbvie pharmaceuticals